Home / Journals / CJU / Online First / doi:10.32604/cju.2025.073002
Special Issues
Table of Content

Open Access

CASE REPORT

Robot-assisted partial nephrectomy during simultaneous extracorporeal membrane oxygenation and impella® in a candidate for left ventricular assist device as a bridge for cardiac transplant: a case report

Francesco Cianflone1, Giuseppe Ottone Cirulli1, Alessio Villano1, Mohammad Eisa Ali1, Mirko Belliato2, Roberto Veronesi2, Germana Bichisao3, Carlo Marchetti1, Simona Secondino4, Paolo Pedrazzoli4,5, Stefano Pelenghi6, Carlo Pellegrini6,7, Andrea Ringressi1, Richard Naspro1,7,*
1 Department of Urology, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy
2 Department of SC AR2-Anesthesia and Cardiothoracic ICU, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy
3 Department of SC AR3-Anesthesia and Post-Surgical Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy
4 Department of Oncology, IRCCS Policlinico San Matteo Foundation, Pavia, 27100, Italy
5 Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, 27100, Italy
6 Cardiac Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy
7 Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, via Alessandro Brambilla, 74, Pavia, 27100, Italy
* Corresponding Author: Richard Naspro. Email: email

Canadian Journal of Urology https://doi.org/10.32604/cju.2025.073002

Received 09 September 2025; Accepted 28 October 2025; Published online 28 November 2025

Abstract

Background: Robot-assisted partial nephrectomy (RAPN) is standard for cT1 renal masses, but its feasibility in patients on temporary mechanical circulatory support is poorly documented. We report RAPN performed while a patient was simultaneously supported with venous-arterial extracorporeal membrane oxygenation (VA ECMO) and Impella®, as part of a staged plan for left ventricular assist device (LVAD) implantation and eventual heart transplantation. Case Presentation: A 51-year-old man presented with ST-elevation myocardial infarction complicated by cardiogenic shock requiring percutaneous coronary intervention with stenting, dual antiplatelet therapy, and combined VA ECMO–Impella® support. During workup for cardiac transplant, computed tomography (CT) staging revealed a 16-mm left renal mass suspicious for renal cell carcinoma. A multidisciplinary team prioritized definitive treatment to preserve transplant eligibility and elected RAPN under systemic heparinization alongside aspirin continuation (cangrelor briefly withheld). Therefore, RAPN was performed with 9 min of warm ischemia. The intraoperative course was hemodynamically stable. On postoperative day (POD) 4, late arterial bleeding from the resection bed was controlled by selective angioembolization. On POD 7, a durable LVAD was implanted as a bridge to heart transplantation. Final pathology showed pT1a, G2, R0 clear cell renal cell carcinoma. At 6 months, contrast-enhanced CT showed no recurrence and no major cardiovascular complications. Conclusions: RAPN during simultaneous ECMO and Impella® support is technically feasible with meticulous anticoagulation management, interventional radiology standby, and coordinated planning. This approach enables oncologic control while preserving a trajectory to transplant candidacy.

Keywords

robot-assisted partial nephrectomy (RAPN); kidney cancer; extracorporeal membrane oxygenation (ECMO); left ventricular assist device (LVAD); cardiac transplant; case report
  • 73

    View

  • 16

    Download

  • 1

    Like

Share Link